Bromelain, Comosain as a New Drug for Treating and Preventing Various Types of Cancer in the Humans

Summary

The Phase II randomized, two-armed clinical study will investigate the efficacy of high dose versus low dose Bromelain (Comosain) in human subjects diagnosed with advanced late stage cancers. The study subjects will be randomly assigned to each group by a coin toss. Bromelain (Comosain) extract, derived from the stem and fruit of Ananas Comosus will be administered orally each day.

Timeline

Start

2014-05

Primary completion

2015-01

Completion

2015-02

Drugs

Indications